Cyclerion Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Cyclerion Therapeutics, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include CYCLERION and CYCLERION THERAPEUTICS. The owner is based in Cambridge, MA.
Riverview II, 18th Floor
245 First Street
Cambridge, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
Cyclerion Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Cyclerion Therapeutics, Inc. have?
Cyclerion Therapeutics, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending, 4 abandoned.
What trademark classes does Cyclerion Therapeutics, Inc. file in?
Cyclerion Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cyclerion Therapeutics, Inc.'s most well-known trademarks?
Cyclerion Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as CYCLERION and CYCLERION THERAPEUTICS. These are among 4 currently registered trademarks in the portfolio.
What is Cyclerion Therapeutics, Inc.'s trademark registration success rate?
Cyclerion Therapeutics, Inc. has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 3 applications are pending review.